Phase II trial of tremelimumab (CP-675,206) in patients with advanced refractory or relapsed melanoma (Q37677908)

From Wikidata
Jump to navigation Jump to search
scientific article published on 19 January 2010
edit
Language Label Description Also known as
English
Phase II trial of tremelimumab (CP-675,206) in patients with advanced refractory or relapsed melanoma
scientific article published on 19 January 2010

    Statements

    Phase II trial of tremelimumab (CP-675,206) in patients with advanced refractory or relapsed melanoma (English)
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit